Biotech · Private company
SparingVision
Track this companyFree. Adds SparingVision to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- SPVN06Phase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Mobility TestRetinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Ophthalmic examinationsRetinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Promising ROd-cone DYstrophy Gene therapYPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Apr 12, 2023ClinicalTrials.gov NCT05748873 · fetched Nov 12, 2026
- Prospective Natural History Study of Retinitis PigmentosaNA · ACTIVE_NOT_RECRUITING · started Feb 12, 2020ClinicalTrials.gov NCT04285398 · fetched Nov 12, 2026